We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$32.9B
AUM Growth
-$855M
Cap. Flow
-$1.68B
Cap. Flow %
-5.1%
Top 10 Hldgs %
29.62%
Holding
1,163
New
73
Increased
397
Reduced
461
Closed
98

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$87.5M
2
SHW icon
Sherwin-Williams
SHW
+$76.1M
3
HD icon
Home Depot
HD
+$68M
4
LIN icon
Linde
LIN
+$55M
5
BMY icon
Bristol-Myers Squibb
BMY
+$50.3M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$95.3M
2
AAPL icon
Apple
AAPL
+$83.2M
3
AVGO icon
Broadcom
AVGO
+$76.2M
4
ELV icon
Elevance Health
ELV
+$71.4M
5
NVDA icon
NVIDIA
NVDA
+$69.2M

Sector Composition

Rank Sector Weight
1 Technology 37.44%
2 Healthcare 14.27%
3 Consumer Discretionary 12.23%
4 Financials 8.85%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSGP icon
701
CoStar Group
CSGP
$12.8B
$2.28M 0.01%
31,894
-3,233
-9% -$244K
DDS icon
702
Dillards
DDS
$10B
$2.28M 0.01%
5,285
+152
+3% +$62.3K
RBLX icon
703
Roblox
RBLX
$35.9B
$2.28M 0.01%
39,328
-8,435
-18% -$424K
XFOR icon
704
X4 Pharmaceuticals
XFOR
$359M
$2.25M 0.01%
102,405
-160
-0.2% -$2.55K
LYV icon
705
Live Nation Entertainment
LYV
$39.7B
$2.24M 0.01%
17,298
-59
-0.3% -$7.43K
NVEE
706
DELISTED
NV5 Global
NVEE
$2.24M 0.01%
118,760
PCG icon
707
PG&E
PCG
$29B
$2.22M 0.01%
110,031
+23,353
+27% +$475K
BDN
708
Brandywine Realty Trust
BDN
$499M
$2.22M 0.01%
396,092
+30,431
+8% +$170K
MOH icon
709
Molina Healthcare
MOH
$10.8B
$2.21M 0.01%
7,584
-15,603
-67% -$4.82M
AAT
710
American Assets Trust
AAT
$1.33B
$2.18M 0.01%
82,969
APLE icon
711
Apple Hospitality REIT
APLE
$3.65B
$2.17M 0.01%
141,332
+4,116
+3% +$63.8K
CFG icon
712
Citizens Financial Group
CFG
$29.6B
$2.16M 0.01%
49,288
+23,112
+88% +$1.02M
EMN icon
713
Eastman Chemical
EMN
$7.53B
$2.15M 0.01%
23,545
-35
-0.1% -$3.59K
VKTX icon
714
Viking Therapeutics
VKTX
$3.49B
$2.15M 0.01%
53,414
-85
-0.2% -$4.85K
EXPO icon
715
Exponent
EXPO
$3.2B
$2.14M 0.01%
24,000
+6,281
+35% +$633K
GM icon
716
General Motors
GM
$74.9B
$2.1M 0.01%
39,452
+6,029
+18% +$316K
QRVO icon
717
Qorvo
QRVO
$10.4B
$2.1M 0.01%
30,039
-25,777
-46% -$2.06M
NTR icon
718
Nutrien
NTR
$37.6B
$2.08M 0.01%
46,535
+6
+0% +$285
ICFI icon
719
ICF International
ICFI
$1.59B
$2.05M 0.01%
+17,167
New +$2.57M
MTX icon
720
Minerals Technologies
MTX
$2.11B
$2.03M 0.01%
26,688
+1,161
+5% +$91.4K
TEX icon
721
Terex
TEX
$6.67B
$2.03M 0.01%
43,966
-32,941
-43% -$1.72M
VMC icon
722
Vulcan Materials
VMC
$32.3B
$2.03M 0.01%
7,881
+5,617
+248% +$1.51M
SPT icon
723
Sprout Social
SPT
$683M
$2.02M 0.01%
65,875
OSIS icon
724
OSI Systems
OSIS
$3.23B
$2.02M 0.01%
12,079
-11,552
-49% -$1.83M
HAL icon
725
Halliburton
HAL
$29.7B
$2.01M 0.01%
73,942
-94,236
-56% -$2.76M

Similar funds

Axa's Q4 2024 Portfolio in Review

As of Q4 2024, Axa held 1,163 positions worth $32.9B, down 2.5% from $33.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Axa withdrew a net $1.68B in Q4 2024, closing 98 positions and reducing 461 holdings. Its most notable exit was Altair Engineering Inc, an estimated $67.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in JBT Marel worth $34.4M.

  • Axa's largest Q4 2024 buy was JBT Marel: 270,829 shares worth $34.4M.
  • Axa added most to Salesforce in Q4 2024, an estimated $87.5M increase.
  • Axa's biggest Q4 2024 reduction was Advanced Micro Devices, cutting an estimated $95.3M.
  • Axa fully exited Altair Engineering Inc in Q4 2024, selling an estimated $67.5M.
  • Axa's ten largest holdings make up 30% of its $32.9B portfolio in Q4 2024.
  • Axa opened 73 new positions and closed 98 in Q4 2024.
  • Axa's portfolio value fell 2.5% quarter-over-quarter to $32.9B.

Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.